Biogen, Inc. (BIIB)
218.11
+1.33
(+0.61%)
USD |
NASDAQ |
Aug 24, 16:00
218.11
0.00 (0.00%)
After-Hours: 20:00
Biogen Total Assets (Quarterly) : 32.09B for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 32.09B |
| March 31, 2026 | 29.48B |
| December 31, 2025 | 29.44B |
| September 30, 2025 | 29.21B |
| June 30, 2025 | 28.33B |
| March 31, 2025 | 28.03B |
| December 31, 2024 | 28.05B |
| September 30, 2024 | 28.31B |
| June 30, 2024 | 26.80B |
| March 31, 2024 | 26.57B |
| December 31, 2023 | 26.84B |
| September 30, 2023 | 28.19B |
| June 30, 2023 | 25.16B |
| March 31, 2023 | 24.60B |
| December 31, 2022 | 24.55B |
| September 30, 2022 | 24.85B |
| June 30, 2022 | 25.08B |
| March 31, 2022 | 23.61B |
| December 31, 2021 | 23.88B |
| September 30, 2021 | 23.81B |
| June 30, 2021 | 24.47B |
| March 31, 2021 | 23.85B |
| December 31, 2020 | 24.62B |
| September 30, 2020 | 24.93B |
| June 30, 2020 | 25.51B |
| Date | Value |
|---|---|
| March 31, 2020 | 26.12B |
| December 31, 2019 | 27.23B |
| September 30, 2019 | 27.48B |
| June 30, 2019 | 26.29B |
| March 31, 2019 | 26.45B |
| December 31, 2018 | 25.29B |
| September 30, 2018 | 25.49B |
| June 30, 2018 | 23.95B |
| March 31, 2018 | 26.09B |
| December 31, 2017 | 23.65B |
| September 30, 2017 | 23.07B |
| June 30, 2017 | 21.76B |
| March 31, 2017 | 21.20B |
| December 31, 2016 | 22.88B |
| September 30, 2016 | 22.10B |
| June 30, 2016 | 21.51B |
| March 31, 2016 | 20.67B |
| December 31, 2015 | 19.50B |
| September 30, 2015 | 20.73B |
| June 30, 2015 | 16.76B |
| March 31, 2015 | 15.22B |
| December 31, 2014 | 14.32B |
| September 30, 2014 | 13.70B |
| June 30, 2014 | 12.92B |
| March 31, 2014 | 12.23B |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Ionis Pharmaceuticals, Inc. | 2.995B |
| AbbVie, Inc. | 135.12B |
| Gilead Sciences, Inc. | 49.36B |
| Vertex Pharmaceuticals, Inc. | 27.42B |
| Amgen, Inc. | 95.64B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 13.24B |
| Shareholders Equity (Quarterly) | 18.85B |
| Debt to Equity Ratio | 0.4433 |
| Current Ratio | 1.865 |
| Net Debt Paydown Yield | -1.09% |